On Invalid Date, Oncology Institute (NASDAQ: TOI) reported Q3 2023 earnings per share (EPS) of -$0.19, up 533.33% year over year. Total Oncology Institute earnings for the quarter were -$17.42 million. In the same quarter last year, Oncology Institute's earnings per share (EPS) was -$0.03.
As of Q1 2024, Oncology Institute's earnings has grown year over year. Oncology Institute's earnings in the past year totalled -$75.41 million.
What is TOI's earnings date?
Oncology Institute's earnings date is Invalid Date. Add TOI to your watchlist to be reminded of TOI's next earnings announcement.
What was TOI's revenue last quarter?
On Invalid Date, Oncology Institute (NASDAQ: TOI) reported Q3 2023 revenue of $82.04 million up 26.25% year over year. In the same quarter last year, Oncology Institute's revenue was $64.98 million.
What was TOI's revenue growth in the past year?
As of Q1 2024, Oncology Institute's revenue has grown 32.79% year over year. This is 24.25 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 8.54%. Oncology Institute's revenue in the past year totalled $309.88 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.